The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Pathogenesis and Management of Lipoprotein Disorders
Abstract
Lipoprotein particles transport cholesterol and triglycerides in the bloodstream. Abnormalities of plasma lipoproteins can result in a predisposition to premature coronary artery disease, pancreatitis, or neurologic disease. Recent advances in our understanding of plasma lipoprotein disorders have contributed to better diagnosis and treatment of these diseases and have provided important insights into normal lipoprotein metabolism. Our purpose is to provide a concise overview of the diagnosis, pathogenesis, and management of lipoprotein disorders.Plasma lipoproteins are generally spherical particles with a surface that consists largely of phospholipid, free cholesterol, and protein, and a core that contains mostly triglyceride and cholesterol ester. . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4696 · Cited by 345
Utermann, G., Jaeschke, M., & Menzel, J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81125-2 · Cited by 337
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.
SNIDERMAN, A. D., WOLFSON, C., TENG, B., FRANKLIN, F. A., BACHORIK, P. S., & KWITEROVICH, P. O. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-833 · Cited by 266
Mabuchi, H., Haba, T., Tatami, R., Miyamoto, S., Sakai, Y., Wakasugi, T., Watanabe, A., Koizumi, J., & Takeda, R. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050902 · Cited by 262
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., Bersot, T. P., Mahley, R. W., & Blum, C. B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111085 · Cited by 141
Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
Havel, R. J., Kotite, L., Kane, J. P., Tun, P., & Bersot, T. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110978 · Cited by 88
Cited by
Kinsella, J., Lokesh, B., & Stone, R. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.1.1 · Cited by 718
The triglyceride issue: A view from Framingham
Castelli, W. P. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90296-6 · Cited by 658
Lipoproteins, nutrition, and heart disease
Schaefer, E. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 438
Self-citationCyclosporin Clinical Pharmacokinetics
Fahr, A. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00004 · Cited by 356
BLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Metadata
- Authors
- Flier, J. S., Underhill, L. H., Schaefer, E. J., & Levy, R. I.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1985-05-16
- Volume
- 312
- Issue
- 20
- Pages
- 1300-1310
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2029396521
- Cited by
- 203
- References
- 7
- FWCI
- 21.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis and Management of Lipoprotein Disorders. https://app.cochat.ai/papers/10.1056/nejm198505163122007
- The paper
- Flier, J. S., Underhill, L. H., Schaefer, E. J., & Levy, R. I. (1985). Pathogenesis and Management of Lipoprotein Disorders. New England Journal of Medicine. https://doi.org/10.1056/nejm198505163122007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.